- Home
- PROK vs TRX Comparison
PROK vs TRX Comparison
Compare PROK & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- TRX
- Stock Information
- Founded
- PROK 2015
- TRX 1990
- Country
- PROK United States
- TRX Canada
- Employees
- PROK N/A
- TRX N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- TRX
- Sector
- PROK Health Care
- TRX
- Exchange
- PROK Nasdaq
- TRX Nasdaq
- Market Cap
- PROK 94.9M
- TRX 90.0M
- IPO Year
- PROK N/A
- TRX N/A
- Fundamental
- Price
- PROK $0.81
- TRX $0.30
- Analyst Decision
- PROK Buy
- TRX Strong Buy
- Analyst Count
- PROK 4
- TRX 1
- Target Price
- PROK $5.00
- TRX $1.50
- AVG Volume (30 Days)
- PROK 796.9K
- TRX 432.6K
- Earning Date
- PROK 05-12-2025
- TRX 04-14-2025
- Dividend Yield
- PROK N/A
- TRX N/A
- EPS Growth
- PROK N/A
- TRX N/A
- EPS
- PROK N/A
- TRX N/A
- Revenue
- PROK $306,000.00
- TRX $45,405,000.00
- Revenue This Year
- PROK N/A
- TRX $51.45
- Revenue Next Year
- PROK N/A
- TRX $26.19
- P/E Ratio
- PROK N/A
- TRX N/A
- Revenue Growth
- PROK N/A
- TRX 26.50
- 52 Week Low
- PROK $0.46
- TRX $0.27
- 52 Week High
- PROK $4.44
- TRX $0.49
- Technical
- Relative Strength Index (RSI)
- PROK 49.17
- TRX 45.42
- Support Level
- PROK $0.94
- TRX $0.30
- Resistance Level
- PROK $0.87
- TRX $0.33
- Average True Range (ATR)
- PROK 0.11
- TRX 0.01
- MACD
- PROK 0.01
- TRX -0.00
- Stochastic Oscillator
- PROK 39.10
- TRX 12.33
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.